Coregulation of glucagon-like peptide-1 synthesis with proglucagon and prohormone convertase 1 gene expression in enteroendocrine GLUTag cells

Endocrinology

Volumn 142, Issue 1, 2001, Pages 37-42

  Dhanvantari, Savita ^a   Izzo, Angelo ^b   Jansen, Erik ^c   Brubaker, Patricia L ^b,d  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FORSKOLIN; FURIN; GLUCAGON LIKE PEPTIDE 1; HORMONE PRECURSOR; ISOBUTYLMETHYLXANTHINE; PROGLUCAGON;

ANIMAL CELL; ARTICLE; ENDOCRINE CELL; ENZYME REGULATION; ENZYME SPECIFICITY; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; HORMONAL REGULATION; INSULIN LIKE ACTIVITY; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN PROCESSING; RECEPTOR GENE;

EID: 0035114987     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.1.7870     Document Type: Article

References (37)

1. Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for type 2-diabetes
2. Glucagon-like peptides
3. On the treatment of diabetes mellitus with glucagon-like peptide-1
4. Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM
5. Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans
6. Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans - Studies with the antagonist exendin 9-39
7. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene
8. Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing
9. Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas
10. Proglucagon processing in islet and intestinal cell lines
11. Role of prohormone convertases in the tissue-specific processing of proglucagon
12. Proglucagon processing in an islet cell line: Effects of PC1 overexpression and PC2 depletion
13. Role of the prohormone convertase PC3 in the processing of proglucagon to glucagon-like peptide 1
14. Processing of mouse proglucagon by recombinant prohormone convertase 1 and immunopurified prohormone convertase 2 in vitro
15. Activation of proglucagon gene transcription by protein kinase A in a novel mouse enteroendocrine cell line
16. Regulation of glucagon-like peptide-1 synthesis and secretion in the GLUTag enteroendocrine cell line
17. Proglucagon gene expression is regulated by a cyclic AMP-dependent pathway in rat intestine
18. Synthesis and secretion of glucagon-like peptided by fetal rat intestinal cells in culture
19. Gene organization of the mouse pro-hormone and pro-protein convertase PC1
20. Neuroendocrine-specific expression of the human prohormone convertase 1 gene. Hormonal regulation of transcription through distinct cAMP response elements
21. Cell type-specific protein-DNA interactions at the cAMP response elements of the prohormone convertase 1 promoter. Evidence for additional transactivators distinct from CREB/ATF family members
22. Stimulation of prohormone convertase-1 mRNA expression by second messenger signaling systems
23. Specific co-ordinated regulation of PC3 and PC2 gene expression with that of preproinsulin in insulin-producing bTC3 cells
24. Mouse insulinoma βTC3 cells express prodynorphin messenger ribonucleic acid and derived peptides: A unique cellular model for the study of prodynorphin biosynthesis and processing
25. Single-step method of RNA isolation by acid guanidimum thiocyanate-phenol-chloroform extraction
26. Control of glucagon-like immunoreactive peptide secretion from fetal rat intestinal cultures
27. Circulating and tissue forms of the intestinal growth factor, glucagon-like peptide-2
28. The biosynthesis of the subtilisin-related proprotein convertase PC3, but not that of the PC2 convertase, is regulated by glucose in parallel to proinsulin biosynthesis in rat pancreatic islets
29. Proteolytic processing mechanisms in the biosynthesis of neuroendocrine peptides: The subtilisin-like proprotein convertases
30. Coordinate regulation of mRNA levels of pro-opiomelanocortin and the candidate processing enzymes PC2 and PC3, but not furin, in rat pituitary intermediate lobe
31. Distribution and regulation of the prohormone convertases PC1 and PC2 in the rat pituitary
32. Prohormone-converting enzymes: Regulation and evaluation of function using antisense RNA
33. Regulation by glucose of the biosynthesis of PC2, PC3 and promsulin in (ob/ob) mouse Islets of Langerhans
34. Glucose-regulated translational control of proinsulin biosynthesis with that of the proinsulin endopeptidases PC2 and PC3 in the insulin-producing MIN6 cell line
35. Proprotein convertases (PC1/PC3 and PC2) in normal and neoplastic human tissues: Their use as markers of neuroendocrine differentiation
36. Proglucagon processing profile in canine L cells expressing endogenous prohormone convertase 1/3 and prohormone convertase 2
37. Encapsulated, genetically engineered cells, secreting glucagon-like peptide-1 for the treatment of non-insulin-dependent diabetes mellitus